FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

21274611000001101: Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70980701000001111 Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70980801000001119 Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Is a Ruxolitinib 20mg tablets 60 tablet true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has AMP Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has specific active ingredient Ruxolitinib phosphate false Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ruxolitinib false Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ruxolitinib true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has basis of strength substance Ruxolitinib true Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has specific active ingredient Ruxolitinib phosphate true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start